Foreword

Curr Probl Cancer. 2009 Jul-Aug;33(4):244. doi: 10.1016/j.currproblcancer.2009.10.001.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / antagonists & inhibitors
  • Biomarkers, Tumor / physiology
  • Drug Delivery Systems
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / physiology
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / etiology
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / therapeutic use
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Receptor, ErbB-2 / physiology

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Protein Kinase Inhibitors
  • ERBB2 protein, human
  • ErbB Receptors
  • Receptor, ErbB-2